Advertisement
Screener

BIOMARIN PHARMACEUTICAL INC (BMRN) Increase (Decrease) in Other Operating Liabilities

2.8 / 5 stars · 68/120 Roast Me

BIOMARIN PHARMACEUTICAL INC Increase (Decrease) in Other Operating Liabilities

BIOMARIN PHARMACEUTICAL INC (BMRN) reported Increase (Decrease) in Other Operating Liabilities of $6.67 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-06

  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was -$2.04M, a 158.74% decline year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $8.70M, a 320.69% increase year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was -$7.02M, a 254.96% decline year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was $16.36M, a 364.63% increase year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for fiscal 2025 was $14.87M, a 0.73% increase from fiscal 2024.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for fiscal 2024 was $14.76M, a 37.41% decline from fiscal 2023.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for fiscal 2023 was $23.59M, a 240.18% increase from fiscal 2022.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other operating liabilities for fiscal 2022 was $6.93M.
Period endIncrease (Decrease) in Other Operating Liabilities 3 monthIncrease (Decrease) in Other Operating Liabilities 6 monthIncrease (Decrease) in Other Operating Liabilities 9 monthIncrease (Decrease) in Other Operating Liabilities 12 monthIncrease (Decrease) in Other Operating Liabilities 12 month as first filed
2026-06-30-$2.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$6.67M
10-Q · filed 2026-08-06
-$356.00K
derived: sum of 3 quarters · filed 2026-08-06
$16.00M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$8.70M
10-Q · filed 2026-05-05
$1.68M
derived: sum of 2 quarters · filed 2026-05-05
$18.04M
derived: sum of 3 quarters · filed 2026-05-05
$21.50M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$7.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$9.33M
derived: sum of 2 quarters · filed 2026-02-26
$12.80M
derived: sum of 3 quarters · filed 2026-08-06
$14.87M
10-K · filed 2026-02-26
2025-09-30$16.36M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$19.82M
derived: sum of 2 quarters · filed 2026-08-06
$21.89M
10-Q · filed 2025-10-28
$26.42M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$3.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$5.54M
10-Q · filed 2026-08-06
$10.07M
derived: sum of 3 quarters · filed 2026-08-06
$13.59M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$2.07M
10-Q · filed 2026-05-05
$6.60M
derived: sum of 2 quarters · filed 2026-05-05
$10.12M
derived: sum of 3 quarters · filed 2026-05-05
$13.52M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$4.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$8.05M
derived: sum of 2 quarters · filed 2026-02-26
$11.45M
derived: sum of 3 quarters · filed 2026-02-26
$14.76M
10-K · filed 2026-02-26
2024-09-30$3.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$6.92M
derived: sum of 2 quarters · filed 2025-10-28
$10.23M
10-Q · filed 2025-10-28
$19.48M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$3.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$6.71M
10-Q · filed 2025-08-05
$15.96M
derived: sum of 3 quarters · filed 2026-02-26
$23.19M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$3.31M
10-Q · filed 2025-05-02
$12.56M
derived: sum of 2 quarters · filed 2026-02-26
$19.79M
derived: sum of 3 quarters · filed 2026-02-26
$22.63M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$9.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$16.48M
derived: sum of 2 quarters · filed 2026-02-26
$19.32M
derived: sum of 3 quarters · filed 2026-02-26
$23.59M
10-K · filed 2026-02-26
2023-09-30$7.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
$10.07M
derived: sum of 2 quarters · filed 2024-10-31
$14.33M
10-Q · filed 2024-10-31
$24.52M
derived: sum of 4 quarters · filed 2025-02-24
2023-06-30$2.84M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05
$7.10M
10-Q · filed 2024-08-05
$17.29M
derived: sum of 3 quarters · filed 2025-02-24
$15.61M
derived: sum of 4 quarters · filed 2025-02-24
2023-03-31$4.26M
10-Q · filed 2024-04-26
$14.45M
derived: sum of 2 quarters · filed 2025-02-24
$12.77M
derived: sum of 3 quarters · filed 2025-02-24
$9.48M
derived: sum of 4 quarters · filed 2025-02-24
2022-12-31$10.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24
$8.51M
derived: sum of 2 quarters · filed 2025-02-24
$5.22M
derived: sum of 3 quarters · filed 2025-02-24
$6.93M
10-K · filed 2025-02-24
2022-09-30-$1.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$4.96M
derived: sum of 2 quarters · filed 2023-11-02
-$3.25M
10-Q · filed 2023-11-02
-$6.86M
derived: sum of 4 quarters · filed 2024-02-26
2022-06-30-$3.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
-$1.58M
10-Q · filed 2023-08-02
-$5.18M
derived: sum of 3 quarters · filed 2024-02-26
-$5.50M
derived: sum of 4 quarters · filed 2024-02-26
2022-03-31$1.71M
10-Q · filed 2023-04-28
-$1.90M
derived: sum of 2 quarters · filed 2024-02-26
-$2.21M
derived: sum of 3 quarters · filed 2024-02-26
-$3.93M
derived: sum of 4 quarters · filed 2024-02-26
2021-12-31-$3.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
-$3.92M
derived: sum of 2 quarters · filed 2024-02-26
-$5.64M
derived: sum of 3 quarters · filed 2024-02-26
-$3.34M
10-K · filed 2024-02-26
2021-09-30-$316.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28
-$2.04M
derived: sum of 2 quarters · filed 2022-10-28
$269.00K
10-Q · filed 2022-10-28
-$15.98M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30-$1.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$585.00K
10-Q · filed 2022-08-04
-$15.67M
derived: sum of 3 quarters · filed 2023-02-27
-$12.38M
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31$2.30M
10-Q · filed 2022-04-29
-$13.95M
derived: sum of 2 quarters · filed 2023-02-27
-$10.66M
derived: sum of 3 quarters · filed 2023-02-27
-$9.87M
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31-$16.25M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
-$12.97M
derived: sum of 2 quarters · filed 2023-02-27
-$12.17M
derived: sum of 3 quarters · filed 2023-02-27
-$7.03M
10-K · filed 2023-02-27
-$6.87M
10-K · filed 2021-02-26
2020-09-30$3.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29
$4.08M
derived: sum of 2 quarters · filed 2021-10-29
$9.22M
10-Q · filed 2021-10-29
$9.97M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$794.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$5.94M
10-Q · filed 2021-07-30
$6.68M
derived: sum of 3 quarters · filed 2022-02-25
-$1.21M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$5.14M
10-Q · filed 2021-04-30
$5.89M
derived: sum of 2 quarters · filed 2022-02-25
-$2.01M
derived: sum of 3 quarters · filed 2022-02-25
$6.80M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$742.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
-$7.15M
derived: sum of 2 quarters · filed 2022-02-25
$1.65M
derived: sum of 3 quarters · filed 2022-02-25
$3.13M
10-K · filed 2022-02-25
2019-09-30-$7.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$912.00K
derived: sum of 2 quarters · filed 2020-11-06
$2.39M
10-Q · filed 2020-11-06
$7.56M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$8.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$10.28M
10-Q · filed 2020-08-05
$15.45M
derived: sum of 3 quarters · filed 2021-02-26
$16.53M
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31$1.47M
10-Q · filed 2020-05-01
$6.64M
derived: sum of 2 quarters · filed 2021-02-26
$7.72M
derived: sum of 3 quarters · filed 2021-02-26
$10.80M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31$5.17M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26
$6.25M
derived: sum of 2 quarters · filed 2021-02-26
$9.32M
derived: sum of 3 quarters · filed 2021-02-26
$8.91M
10-K · filed 2021-02-26
2018-09-30$1.08M
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04
$4.15M
derived: sum of 2 quarters · filed 2019-11-04
$3.74M
10-Q/A · filed 2019-11-04
$6.04M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$3.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$2.66M
10-Q · filed 2019-08-02
$4.96M
derived: sum of 3 quarters · filed 2020-02-27
$5.00M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31-$408.00K
10-Q · filed 2019-04-29
$1.89M
derived: sum of 2 quarters · filed 2020-02-27
$1.93M
derived: sum of 3 quarters · filed 2020-02-27
$2.64M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$2.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$2.33M
derived: sum of 2 quarters · filed 2020-02-27
$3.05M
derived: sum of 3 quarters · filed 2020-02-27
$5.79M
10-K · filed 2020-02-27
2017-09-30$38.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26
$753.00K
derived: sum of 2 quarters · filed 2018-10-26
$3.50M
10-Q · filed 2018-10-26
$2.54M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$715.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
$3.46M
10-Q · filed 2018-08-03
$2.50M
derived: sum of 3 quarters · filed 2019-02-28
$6.10M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$2.74M
10-Q · filed 2018-04-27
$1.78M
derived: sum of 2 quarters · filed 2019-02-28
$5.39M
derived: sum of 3 quarters · filed 2019-02-28
$1.95M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$962.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$2.65M
derived: sum of 2 quarters · filed 2019-02-28
-$799.00K
derived: sum of 3 quarters · filed 2019-02-28
-$5.41M
10-K · filed 2019-02-28
2016-09-30$3.61M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
$163.00K
derived: sum of 2 quarters · filed 2017-10-31
-$4.45M
10-Q · filed 2017-10-31
-$4.49M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30-$3.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
-$8.06M
10-Q · filed 2017-08-02
-$8.10M
derived: sum of 3 quarters · filed 2018-02-26
-$14.38M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31-$4.61M
10-Q · filed 2017-05-04
-$4.66M
derived: sum of 2 quarters · filed 2018-02-26
-$10.94M
derived: sum of 3 quarters · filed 2018-02-26
-$13.05M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31-$43.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
-$6.32M
derived: sum of 2 quarters · filed 2018-02-26
-$8.44M
derived: sum of 3 quarters · filed 2018-02-26
$747.00K
10-K · filed 2018-02-26
2015-09-30-$6.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
-$8.40M
derived: sum of 2 quarters · filed 2016-11-03
$790.00K
10-Q · filed 2016-11-03
$4.00M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30-$2.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
$7.07M
10-Q · filed 2016-08-08
$10.28M
derived: sum of 3 quarters · filed 2017-02-27
$11.35M
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31$9.19M
10-Q · filed 2016-05-02
$12.39M
derived: sum of 2 quarters · filed 2017-02-27
$13.46M
derived: sum of 3 quarters · filed 2017-02-27
$11.69M
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31$3.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$4.28M
derived: sum of 2 quarters · filed 2017-02-27
$2.51M
derived: sum of 3 quarters · filed 2017-02-27
$3.09M
10-K · filed 2017-02-27
2014-09-30$1.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
-$703.00K
derived: sum of 2 quarters · filed 2015-11-02
-$116.00K
10-Q · filed 2015-11-02
$4.08M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30-$1.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
-$1.18M
10-Q · filed 2015-08-05
$3.01M
derived: sum of 3 quarters · filed 2016-02-29
$6.36M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$587.00K
10-Q · filed 2015-05-05
$4.78M
derived: sum of 2 quarters · filed 2016-02-29
$8.13M
derived: sum of 3 quarters · filed 2016-02-29
$7.37M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$4.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$7.54M
derived: sum of 2 quarters · filed 2016-02-29
$6.79M
derived: sum of 3 quarters · filed 2016-02-29
$9.56M
10-K · filed 2016-02-29
2013-09-30$3.35M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28
$2.59M
derived: sum of 2 quarters · filed 2014-10-28
$5.37M
10-Q · filed 2014-10-28
$2.78M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30-$757.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31
$2.02M
10-Q · filed 2014-07-31
-$574.00K
derived: sum of 3 quarters · filed 2015-03-02
$3.82M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$2.77M
10-Q · filed 2014-05-02
$183.00K
derived: sum of 2 quarters · filed 2015-03-02
$4.57M
derived: sum of 3 quarters · filed 2015-03-02
$7.42M
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31-$2.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
$1.80M
derived: sum of 2 quarters · filed 2015-03-02
$4.65M
derived: sum of 3 quarters · filed 2015-03-02
$6.03M
10-K · filed 2015-03-02
2012-09-30$4.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28
$7.24M
derived: sum of 2 quarters · filed 2013-10-28
$8.63M
10-Q · filed 2013-10-28
$9.57M
derived: sum of 4 quarters · filed 2014-02-26
2012-06-30$2.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29
$4.24M
10-Q · filed 2013-07-29
$5.18M
derived: sum of 3 quarters · filed 2014-02-26
$5.63M
derived: sum of 4 quarters · filed 2014-02-26
2012-03-31$1.39M
10-Q · filed 2013-04-29
$2.33M
derived: sum of 2 quarters · filed 2014-02-26
$2.78M
derived: sum of 3 quarters · filed 2014-02-26
$2.79M
derived: sum of 4 quarters · filed 2014-02-26
2011-12-31$943.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26
$1.39M
derived: sum of 2 quarters · filed 2014-02-26
$1.40M
derived: sum of 3 quarters · filed 2014-02-26
$1.96M
10-K · filed 2014-02-26
2011-09-30$450.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29
$459.00K
derived: sum of 2 quarters · filed 2012-10-29
$1.02M
10-Q · filed 2012-10-29
$1.88M
derived: sum of 4 quarters · filed 2013-02-26
2011-06-30$9.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
$569.00K
10-Q · filed 2012-08-02
$1.43M
derived: sum of 3 quarters · filed 2013-02-26
$2.12M
derived: sum of 4 quarters · filed 2013-02-26
2011-03-31$560.00K
10-Q · filed 2012-04-30
$1.42M
derived: sum of 2 quarters · filed 2013-02-26
$2.11M
derived: sum of 3 quarters · filed 2013-02-26
$1.41M
derived: sum of 4 quarters · filed 2013-02-26
2010-12-31$860.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
$1.55M
derived: sum of 2 quarters · filed 2013-02-26
$851.00K
derived: sum of 3 quarters · filed 2013-02-26
$1.90M
10-K · filed 2013-02-26
2010-09-30$693.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31
-$9.00K
derived: sum of 2 quarters · filed 2011-10-31
$1.04M
10-Q · filed 2011-10-31
$221.00K
derived: sum of 4 quarters · filed 2012-02-22
2010-06-30-$702.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01
$347.00K
10-Q · filed 2011-08-01
-$472.00K
derived: sum of 3 quarters · filed 2012-02-22
-$88.00K
derived: sum of 4 quarters · filed 2012-02-22
2010-03-31$1.05M
10-Q · filed 2011-04-29
$230.00K
derived: sum of 2 quarters · filed 2012-02-22
$614.00K
derived: sum of 3 quarters · filed 2012-02-22
2009-12-31-$819.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22
-$435.00K
derived: sum of 2 quarters · filed 2012-02-22
$687.00K
10-K · filed 2012-02-22
2009-09-30$384.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29
$1.51M
10-Q · filed 2010-10-29
2009-06-30$1.12M
10-Q · filed 2010-08-04
2008-12-31$78.00K
10-K · filed 2011-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05